Addiction Psychiatry — Specialty Profile

Exploratory, not prescriptive. This profile blends hard data (pay, fill rates, burnout, demographics — each sourced and dated) with generalizations and synthesized online opinion about culture and "who fits." It's here to help you get curious and go find out for yourself — not to tell you who to become. Numbers marked ⟳ verify change every year; check the linked source before you quote one. Last reviewed: 2026-07-25.

Also called: ADP, addiction psych. Subspecialty fellowship of Psychiatry. Organ system: the brain's reward circuitry and the mind entangled with it, though really the whole person, since substance use disorders and the mental illness that so often rides alongside them touch every part of a life.

The 30-second version

Addiction psychiatry is the psychiatry-native path into one of medicine's most urgent crises: treating substance use disorders as the chronic, treatable diseases they are, with a specific mastery of the mental illness tangled up with them. You manage opioid, alcohol, and stimulant use disorders mostly in the outpatient setting, prescribing buprenorphine, methadone, and naltrexone, doing psychotherapy and relapse-prevention work, and practicing harm reduction. But your distinguishing expertise is dual diagnosis: the reciprocal knot of depression, bipolar disorder, PTSD, or psychosis and addiction, treated as one person rather than two problems.¹ The day-to-day looks like chronic-disease management rather than acute rescue, closer to managing diabetes than curing pneumonia. What makes it distinctive is the combination, since the schedule is unusually livable: some of the most concretely life-saving work in medicine, carried inside a system that funds it grudgingly and a culture that still stigmatizes both the field and its patients, reached through only one extra year after a psychiatry residency you'd be doing anyway.

Quick dashboard (details and sources below)


Training after med school	5 years (4 yr general psychiatry residency + 1 yr Addiction Psychiatry fellowship)
Total from college start	~13 years (4 undergrad + 4 med school + 4 residency + 1 fellowship)
Competitiveness (as a fellowship)	Low — genuinely accessible; ~69% fill, roughly 3 in 10 spots go unfilled ⟳
Typical full-time pay	Inferred from psychiatry · no direct data. No survey publishes addiction psychiatry. General psychiatry runs $331,000 (Medscape 2026) to $341,977 (Doximity 2025); plan around that ⟳
Pay range (structure)	No published percentile table exists for this subspecialty. Setting drives the spread: academic and community mental health at the bottom, cash-pay and telehealth panels and directorship stipends at the top ⟳
Lifestyle	Largely outpatient, minimal call, telehealth-friendly, ~42 hr/week ⟳
Burnout	Low: inherits psychiatry's 31.6% against a 41.9% all-physician average (AMA Organizational Biopsy 2025); strain, when it comes, is emotional and systemic rather than a matter of hours ⟳
DO / IMG accessibility	Very open — matched cohort ~10% DO, ~12% US-IMG; base field among the most IMG/DO-friendly ⟳

Entry note: you do not match into addiction psychiatry out of medical school. You first complete a general psychiatry residency (an accessible, DO/IMG-friendly base), then apply during residency to a 1-year fellowship through the NRMP Medicine & Pediatric Specialties Match. Board certification is an ABPN subspecialty in Addiction Psychiatry, certified since 1993.

What they actually do

Addiction psychiatrists evaluate, diagnose, and treat people with one or more substance use disorders (SUDs), including alcohol, opioids, stimulants, sedatives, and tobacco, as chronic, relapsing medical conditions. What sets the field apart from the broader addiction workforce is its center of gravity in co-occurring psychiatric illness ("dual diagnosis"): mood, anxiety, psychotic, trauma, and personality disorders intertwined with addiction, treated as one integrated picture of a person rather than two separate charts.¹ The core of the job is longitudinal outpatient care (office-based treatment of opioid use disorder with buprenorphine, oversight of methadone in opioid treatment programs, naltrexone and alcohol-use-disorder pharmacotherapy) layered over the full psychiatric management, medications and psychotherapy both, that a dual-diagnosis patient needs.¹

The work is cognitive and relationship-driven, essentially non-procedural, and the "procedure" is the medication, the plan, and the therapeutic relationship. You manage withdrawal (opioid, alcohol, benzodiazepine), practice harm reduction (naloxone, safer-use counseling), deliver or supervise psychotherapy and group work (motivational interviewing, CBT, relapse prevention), and treat behavioral (non-substance) addictions such as gambling.¹ Because addiction psychiatrists combine full psychiatric training with addiction expertise, they are central to the most complex dual-diagnosis cases and to the clinical frontline of the overdose/opioid crisis.¹²

Representative work: buprenorphine induction and maintenance · methadone/OTP oversight · naltrexone and alcohol-use-disorder pharmacotherapy · management of withdrawal/detoxification · integrated treatment of co-occurring mood, anxiety, PTSD, and psychotic disorders · psychotherapy and group therapy (motivational interviewing, CBT, relapse prevention) · harm-reduction counseling · addiction consult-liaison work in the general hospital. There are no significant surgical or device-based procedures. Buprenorphine prescribing once required a special DEA "X-waiver," but that was eliminated by the MAT Act in 2023, so any DEA-registered prescriber can now offer it.¹³

A day in the life: Mostly clinic, and mostly people you know over time. You see a panel that mixes patients stable on buprenorphine and doing well, patients who relapsed since last visit, and new, ambivalent ones. And because this is psychiatry, you're also managing their depression, their bipolar disorder, and their trauma at the same visit.¹ There's medication management, psychotherapy, and a lot of listening. A large and growing share of MAT/dual-diagnosis follow-up is telehealth.¹⁴ If you cover an inpatient dual-diagnosis unit, a detox service, or a hospital addiction consult service, you round on admitted patients; overnight call is minimal in most settings. When the day ends you generally go home. The load you carry out the door is emotional rather than logistical.

The training path & time to completion

Medical school (4 yrs) → General Psychiatry residency (4 yrs) → Addiction Psychiatry fellowship (1 yr, PGY-5) → board-eligible with an ABPN subspecialty certificate in Addiction Psychiatry.¹ This is a two-step entry: you match into psychiatry residency straight from medical school, then apply again during residency to a one-year fellowship through the NRMP Medicine & Pediatric Specialties Match (though many programs also fill on a rolling/direct basis; see competitiveness).⁵

Fellowship (1 yr): ACGME-accredited; a continuous block of at least half-time addiction psychiatry training completed after general psychiatry residency (part-time arrangements can stretch it to ~2 yrs). The residency psychiatry curriculum does not count toward it, and international programs are not accepted.¹
Board: the American Board of Psychiatry and Neurology (ABPN). Subspecialty certification requires prior ABPN certification in general psychiatry (by December 31 of the year before the exam), completion of the accredited fellowship, and an active unrestricted license. The subspecialty exam is offered every two years.¹
A mature subspecialty. ABPN has certified Addiction Psychiatry since 1993, a well-established, three-decade-old credential, in contrast to Addiction Medicine, recognized by ABMS only in 2015–16 (see below). Accredited fellowships grew from ~13 in 1997 to roughly 45–54 today.²⁶
Total from the start of college: ~13 years (4 undergrad + 4 med school + 4 residency + 1 fellowship). That's 5 years after medical school, only one more than a general psychiatrist.¹

The distinction that trips people up: Addiction Psychiatry vs. Addiction Medicine

These are two different credentials for closely overlapping work, and premeds constantly conflate them, so be precise. Addiction Psychiatry (this page) is a psychiatry subspecialty: you must finish a general psychiatry residency first, the board is ABPN, and the emphasis is weighted toward psychiatric comorbidity and dual diagnosis on top of addiction pharmacotherapy and psychotherapy.¹⁷ Addiction Medicine is a multidisciplinary subspecialty (board: the American Board of Preventive Medicine, ABPM), enterable from almost any base residency (internal medicine, family medicine, emergency medicine, pediatrics, psychiatry, and more) with a scope that reaches further into the general-medical management of addiction (hepatitis, HIV, withdrawal on the wards) and public health.⁷ A psychiatrist can pursue either; addiction psychiatry is simply the psychiatry-native route, and some physicians hold both. If your base field is (or will be) something other than psychiatry, the multidisciplinary route is your door; see the companion Addiction Medicine profile for that path in depth. This page is about the ABPN, psychiatry-based route specifically.⁷

How competitive is it?

Because addiction psychiatry is a fellowship, competitiveness works differently than for a base residency, and here the story is unusually friendly. The hard part of this path is getting into and through a general psychiatry residency (moderately competitive and quietly rising, but genuinely DO/IMG-accessible). The fellowship step itself is one of the most reachable in all of medicine.⁵

2026 NRMP Specialties Matching Service (Addiction Psychiatry):⁵

47 programs · 112 positions offered · 77 filled → 68.8% fill rate. ⟳
That means 35 positions (~31%) went unfilled through the match, and 22 programs ended the match with an empty seat. This is the opposite of the ultra-competitive-match anxiety premeds hear about elsewhere.
87 total applicants ranked the specialty → an applicant-to-position ratio of about 0.78 (fewer applicants than positions), about as applicant-friendly as an ACGME fellowship gets.⁵
The fill rate swings, and one adjacent pair is not a trend. NRMP's four-year series reads 65.2% (2023) · 50.8% (2024) · 58.7% (2025) · 68.8% (2026), on 115, 124, 104 and 112 positions. Against 2023 the four-year move is 3.6 points. Against 2024 it is eighteen. On a base near 110 positions, a handful of programs choosing not to recruit moves the rate by several points, so read this number as a band rather than a direction.⁵ ⟳
Match numbers understate true capacity. Not every accredited program runs through the NRMP, and unfilled and non-match positions are filled on a rolling or direct-application basis, so real accessibility is higher than the fill rate suggests.⁵

Program counts: ~54 ACGME-accredited Addiction Psychiatry programs (52 on continued accreditation, 2 initial) as of 2024–25.⁶

IMG/DO-friendliness runs high. Of the 77 positions filled in 2026: US MD 70.1%, US DO 10.4%, US-citizen IMG 11.7%, non-US IMG 7.8%.⁸ Non-US-MD graduates together took about 3 in 10 spots, consistent with general psychiatry being among the more open fields in medicine, layered under an undersubscribed subspecialty. (These are matched-cohort shares by medical-school type, so they describe one entering class rather than the field; see Demographics.)⁸⁹

The context that explains all of it: a deep workforce shortage meets an ongoing overdose crisis, and the training pipeline hasn't caught up. Like the broader addiction world, this is a field people tend to find rather than gun for from day one, which is exactly why it stays reachable for a motivated psychiatry resident from any background.

Compensation — the robust version

Addiction psychiatry is a cognitive, largely outpatient, non-procedural field, so total comp sits in the moderate band, solidly above the all-specialty median but well below procedural specialties. No survey publishes a number for it. Medscape's 29 specialties stop at "psychiatry," Doximity does the same, and neither breaks out a single psychiatry subspecialty. The figures that circulate under this field's name come from job boards and salary aggregators, and this page carried three of them until August 2026. They are gone rather than downgraded, because a scraped job-posting average is not weak evidence about what addiction psychiatrists earn; it is evidence about what job postings say.¹⁰

The anchor, and the reasoning. Plan around general psychiatry: $331,000 in Medscape's 2026 report on 2025 earnings, $341,977 in Doximity's 2025 report on 2024 earnings.¹¹ ⟳ The credential should land you at or a little above that. The reasoning is that addiction psychiatry adds demand rather than a new billing category, since the work is the same evaluation-and-management codes a general psychiatrist bills, and the shortage is severe enough to command something. What it does not do is move you into a procedural pay tier, because there are no procedures. Reasoning, not a measurement, and the size of any premium is unknown.

The spread comes from the practice model, not from seniority. A salaried community mental health or academic job and an owner-operated cash-pay telehealth panel are different businesses wearing the same specialty name, and the gap between them is wider than anything the fellowship itself moves. No percentile table for this subspecialty is published, and building one out of the parent field's would be inventing it.

Setting.

Academic / fellowship faculty: typically the lowest clinical pay, offset by protected time, teaching, research, and stability. Addiction psychiatry has a large academic footprint (54 programs).⁶
VA / government: a major employer of addiction psychiatrists, with solid, stable pay, PSLF eligibility, and VA EDRP loan repayment up to $200,000.¹²
Community mental health / nonprofit / FQHC: high job volume, mission-heavy, mid-band pay, PSLF-eligible, with NHSC loan repayment up to $50,000 for a full-time two-year commitment in a Mental Health HPSA — or up to $100,000 through the separate Rural Community LRP, which asks for three years of substance-use-disorder treatment at a rural approved site and is the one NHSC route this field fits better than any other.¹²
Private practice / cash-pay / telehealth: the highest ceiling. Owners of buprenorphine/MAT or cash-pay/telepsych panels can go well past a salaried job on panel size and low overhead, which is where the field's upper tier lives.³
Treatment centers (residential/IOP/OTP): mid-range salaried clinical roles, with a medical directorship stipend stacking on top.³

Geography is two-sided, same as psychiatry generally. High-cost coastal metros pay high nominal salaries, and rural/underserved markets pay premiums to attract scarce clinicians, often layered with loan-repayment and opioid-settlement/grant sweeteners. Psychiatry pay tends to invert the usual prestige gradient, with rural, Mountain West and Midwest markets often paying more than coastal hubs, a dynamic that applies directly here given the shortage. ⟳

Income levers, which is where the ceiling actually comes from.

Cash-pay and telehealth MAT panels. Since the 2023 removal of the DEA X-waiver, any DEA-registered prescriber can build a buprenorphine panel, and remote SUD roles are abundant.³
Treatment-center medical directorships, whose stipends stack on clinical income.³
Locum tenens, which pays an hourly rate well above the employed equivalent in exchange for no benefits and no stability.
Forensic and expert-witness side work, meaning drug-court and correctional consulting.

The trend that colors all of it. Demand is structurally strong. A tiny workforce of roughly ~2,000 ABPN-certified addiction psychiatrists sits against ~46+ million Americans with SUDs, an ongoing overdose crisis, and sustained federal, state, and opioid-settlement funding much of it aimed at the underserved areas that also carry pay premiums.¹³¹⁴ The cross-current is that psychiatry's own base pay has been flat to slightly down in the most recent reports, so incremental upside increasingly comes from the levers above rather than from a rising salary.¹¹ ⟳

Lifestyle & the livable-schedule bargain

The most-cited pro of addiction psychiatry: it sits at the livable end of an already-livable field, and that's structural, not luck. It inherits psychiatry's lifestyle profile and then leans even more outpatient and longitudinal. Self-reported psychiatry and addiction work both cluster around a ~42-hour week with high schedule control (no ADP-specific hours survey exists, so treat ~40–45 hrs as the working estimate for a standard outpatient role).⁴¹⁵

Call is light. Office-based buprenorphine/naltrexone management, dual-diagnosis clinics, and treatment-program oversight carry little to no overnight call. Heavier settings exist (inpatient dual-diagnosis units, addiction consult-liaison, ED/detox, correctional), but even those are shift- or rounding-based rather than surgical-style call.⁴
Telehealth-friendly. Psychiatry is among the most remote-capable fields in medicine, and MAT translated cleanly to video, so a largely-daytime, partly-or-fully-remote practice is realistic.⁴
Combinable and easy to taper. Because the work is cognitive and non-procedural, it scales down cleanly: job-share, part-time, or a dual-diagnosis/MAT clinic bolted onto a general-psych practice a couple of days a week are all easy to build.⁴

The most-cited con is the patients you carry. Addiction is a chronic, relapsing disease and the overdose crisis is the backdrop of the whole specialty. Some patients you know well will relapse, disappear, overdose, or die. The demanding part of this field is emotional and systemic, not logistical (see Wellbeing).

Lifestyle rating: 4/5. Genuinely high schedule control, minimal call, remote-workable, and sustainable for decades, with the honest asterisk that the emotional load is heavy even when the calendar is light. (Consistent with the 4/5 assigned to both general psychiatry and addiction medicine in the sibling profiles.)⁴¹⁵

Wellbeing — the part to take seriously

Burnout is low, and this field inherits psychiatry's standing. General psychiatry runs among the lowest burnout in medicine. The AMA's 2025 Organizational Biopsy, which surveyed nearly 19,000 physicians across 38 states, puts it at 31.6% against a 41.9% all-physician average, one of the six lowest specialties it names. Medscape's Physician Burnout & Depression Report 2024 (2023 data, 9,226 physicians) is the second instrument and reads higher throughout: psychiatry ~39%, tied roughly 2nd-lowest of the twenty rows it publishes, against emergency medicine at 63%.¹⁶ No ADP-isolated burnout figure is published, so this is the parent-field anchor, but the burnout that does surface in addiction work is sourced differently than in high-acuity fields. It rarely comes from hours or call. Qualitative research on hospital-based addiction providers ties strain specifically to systemic under-resourcing and stigma, while meaning, purpose, and team support build resilience. The toll is structural rather than from the patients.¹⁷ Three named drivers:

The emotional load of relapse and mortality. With tens of thousands of US overdose deaths a year, loss is structural to the work, not occasional. You keep showing up for people the disease keeps pulling back.
Stigma against the field itself. Colleagues who view the patients as less deserving or the specialty as lower-status; that secondhand contempt is a documented burnout driver.¹⁷¹⁸
A system that undervalues the work. Precarious reimbursement, staffing, and politically volatile support for MAT and harm reduction.¹⁷

Meaning runs very high, on the frontline of the overdose crisis. This is the strongest single note in the wellbeing column. AAAP frames addiction psychiatrists as central to "the biggest public health challenge facing the United States," against the 48.5 million Americans aged 12 or older, 17.1% of that population, who met criteria for a past-year substance use disorder in 2023.¹³ ⟳ People consistently describe some of the most concretely life-saving work in medicine, since buprenorphine genuinely pulls people back from death and you see it, and that sense of purpose is the major protective factor against the emotional load.¹⁷¹³

Satisfaction reads high, but no one publishes a number for it. There is no addiction-psychiatry figure, and the by-specialty "would choose the specialty again" tables that circulate online have no publisher behind them. What is published sits one level up: psychiatry is consistently among the specialties whose members most often say a doctor in the field can be happy and well-balanced.¹⁵ Treat the rest as impression rather than measurement.

Career longevity is a quiet strength. Low physical/procedural stress (no OR, no radiation, no brutal overnight surgical call), a controllable and combinable schedule, and easy tapering to part-time or telehealth make this a field people sustain for decades, or step into mid-career as a lower-intensity, higher-meaning pivot from a harder specialty.⁴¹⁵

Honest framing: the people who thrive here are the ones for whom the meaning outweighs the loss, and many genuinely find that it does.

Who's in the field (demographics)

Sex is published for the fellows; race and the practicing workforce are not. ACGME's Data Resource Book AY2024-25, Table C.21, gives addiction psychiatry 54 programs and 79 fellows, 32 of them women (40.5%) and 47 men (59.5%), with none unreported. That is a small row and a trainee census rather than a workforce count, so read it as what it is. Race and ethnicity have no addiction-psychiatry breakdown anyone can use, and the practicing subspecialty has no demographic table at all: AAMC's workforce dashboard leaves out any specialty under 2,500 active physicians, which covers addiction psychiatry.⁹ ⟳

What can be said:

Entering-fellow mix by school type (2026 NRMP, 77 matched, a proxy rather than an official demographic table): US MD 70.1%, US DO 10.4%, US-IMG 11.7%, non-US IMG 7.8%.⁸ Just under 30% of the entering cohort came from outside US MD schools.
Women: 40.5% of current addiction psychiatry fellows, 32 of 79 (ACGME AY2024-25). For the practicing subspecialty no figure is published, so the parent field is the proxy: ~42–44% of practicing psychiatrists are women (2022), above the all-physician average (~38.7%, 2024).⁹ ⟳
IMG (practicing parent field): ~29% of practicing psychiatrists are IMGs (2020), one of the highest shares of any specialty; addiction psychiatry draws from this pool.⁹ ⟳
Workforce size: roughly ~2,000 board-certified addiction psychiatrists (ABPN), a tiny subspecialty against ~46+ million Americans with SUDs. Scarcity underpins durable demand and negotiating leverage.¹³¹⁴ ⟳
Race/ethnicity: no addiction-psychiatry-specific breakdown is published; even psychiatry-level figures aren't cleanly reported (AAMC gives only all-physician baselines). Flagged, not invented.⁹ ⟳

(Per site policy, we do not report a per-specialty first-generation statistic, because no reliable data exists, but the FLI angle below is the point of this whole site.)

Culture, personality & the online stereotypes

Kind realism: the patterns below are the field's online and community reputation, not gospel. Plenty of people don't fit them, and this is a population and a field that have both been badly served by lazy characterization, so read them as attributed perception, note the exceptions, not a verdict.

Who gravitates here: the reputation is that addiction psychiatry draws mission-driven, non-judgmental, harm-reduction-minded physicians, socially conscious people who find meaning caring for a stigmatized, underserved population much of the rest of medicine would rather avoid.¹⁹ The read online is that it selects for people comfortable with chronic, relapsing disease and slow, partial wins ("slow medicine," meaning relationship-building over months, closer to managing diabetes than curing pneumonia), who don't need the ego reward of a dramatic save, and who can hold hope for a patient the system has written off. It's said to draw the resilient (relapse is part of the work, not a failure) and the advocacy-driven, comfortable with marginalized patients, and the addiction-psychiatry flavor specifically adds a pull for people fascinated by dual diagnosis, the reciprocal tangle of mental illness and substance use. It's also described as a notably welcoming, less status-obsessed corner of medicine, with far less ego-jockeying than more prestigious fields.¹⁹

The stereotypes. community caricatures, not facts. Each with a humanizing counterpoint:

"The lowest-status specialty." Reframed honestly: the low status reflects stigma against the patients rather than the difficulty or value of the work, and the field exists precisely to counter that bias.
"You're just a legal drug dealer." A cruel jab at buprenorphine prescribing. Reality: MAT is among the best-evidenced, most life-saving interventions in all of medicine, and the caricature is the exact misconception the field fights.
"Nothing works. Everyone relapses." Reframes a chronic, relapsing disease as a personal failing. Relapse is part of the disease course, and partial wins genuinely save lives; the "slow medicine" mindset is the expertise, not a consolation prize.
"A soft, easy lifestyle field." The schedule is livable, true, but the framing misses that the difficulty here is emotional and systemic rather than a lack of rigor.

What people say online (synthesized and paraphrased from public discussion, not quoted): the picture is strikingly consistent and two-sided. People describe some of the most rewarding, most-needed work in medicine and are unusually vocal that they'd choose it again, and the "you actually save lives and see it" sentiment recurs. The lifestyle draws praise for controllable hours, minimal call, telehealth, and easy part-time work, a top reason to add addiction work to a psych base, and it's widely flagged as accessible and undersubscribed. The frustrations are consistently external, not about the work itself: stigma from colleagues who look down on the patients or the field, under-resourced systems that fund MAT and harm reduction grudgingly, and regulatory friction around controlled-substance prescribing. And the emotional toll is named honestly, with patient deaths and relapse as the real cost.¹⁹

Voices from the field. Paraphrased from public writing, with links to the originals:

Taylor Moss, MPH & Devika Bhushan, MD argue that stigma and "medical gaslighting" around addiction actively cost lives, with fewer than 1 in 5 of the ~48 million Americans with a SUD getting treatment, and that addiction specialists are the clinicians most likely to treat it as the disease it is.¹⁸
Dr. Megana Dwarakanath frames harm reduction as being as fundamental as "do no harm," and captures the emotional core of the work in a patient who, for the first time, was not feeling ashamed.²⁰
Serowik and colleagues, studying hospital-based addiction providers, find burnout driven by systemic under-resourcing and stigma while meaning, purpose, and team support build resilience. The toll is structural rather than from the patients.¹⁷
Workforce researchers repeatedly call addiction care "one of medicine's best-kept secrets," a genuine growth area people tend to find by accident rather than by design, and a big reason the shortage persists despite booming demand.²¹

Why people choose it / why people leave

Why choose it: genuinely life-saving, high-meaning work where you see the impact directly · dual-diagnosis depth, treating the whole person (mood/psychosis/trauma and the substance use) rather than half of them · controllable lifestyle, with predictable hours, minimal call, telehealth, and part-time and hybrid options · only one extra year after psychiatry residency · strong, durable, crisis-driven demand and a nationwide shortage that translates to autonomy and geographic freedom · combinable with a general-psych practice · loan-repayment-eligible roles common · a welcoming, less status-obsessed culture.

Why leave or avoid it: the emotional load of relapse and death is real and recurring · stigma from colleagues and society attaches to the field and its patients · systemic headwinds including grudging funding, regulatory friction, and political volatility around MAT/harm reduction · pay is near/above general psych but moderate relative to procedural specialties · you're often swimming against a system that undervalues work you know saves lives.

Best fit if: you find meaning in caring for people the rest of medicine overlooks and don't need prestige or a dramatic save to feel it was worth it · you're specifically drawn to the dual-diagnosis tangle of mental illness plus substance use · you're comfortable with chronic, relapsing disease and slow, partial wins · you want real work-life balance and schedule control without leaving direct patient care · harm reduction and meeting people where they are resonate with you.

Not for you if: recurring patient loss and relapse would be emotionally unsustainable · you need high status, top-tier pay, or unambiguous cures to feel satisfied · you'd resent working inside an under-resourced, politically contested part of the system · you prefer acute, procedure-heavy, fast-resolution medicine.

The FLI angle — Addiction Psychiatry for first-gen, low-income & immigrant students

This is one of the most FLI-favorable subspecialties in medicine, and it's honest to say so plainly.

Where it fits FLI realities exceptionally well:

Accessible and undersubscribed. The fellowship runs well below capacity, at 77 of 112 positions filled (68.8%) in the 2026 match, with 35 seats going unfilled and fewer applicants than positions.⁵ AAAP openly describes "a critical need for addiction psychiatrists," with faculty and staff positions unfilled for extended periods.¹³ This is the opposite of ultra-competitive-match anxiety.
IMG/DO-friendly, top to bottom. The base field, general psychiatry, is among the more open in all of medicine (~29% of practicing psychiatrists are IMGs; DOs took ~23% of matched 2025 psychiatry PGY-1 spots), and the addiction fellowship's matched 2026 cohort ran ~10% DO, ~12% US-IMG and ~8% non-US IMG.⁸⁹ An undersubscribed subspecialty layered on an IMG/DO-accessible base is about as reachable as fellowships get. (No clean ADP-specific %IMG/%DO is published; this is a directional inference from the base field plus the low fill rate.)
Only one extra year. A single PGY-5 fellowship year (part-time up to ~2 yrs) added onto a residency you'd do anyway, a low-risk, low-cost add-on that matters more when there's no financial cushion behind you.¹
Enormous, funded demand = job security almost anywhere. The overdose crisis has created durable demand with real money behind it (federal/SAMHSA/HRSA grants, opioid-settlement dollars, loan-repayment programs), including in rural and underserved areas where telehealth-MAT lets you practice from, or near, home.¹³¹⁴
PSLF-rich employers. The natural homes for this work (VA, community mental health, nonprofit/FQHC, correctional, public health) are disproportionately PSLF-qualifying and loan-repayment-eligible (NHSC up to $50k for two years in a Mental Health HPSA, or up to $100k for three years of rural SUD work; VA EDRP up to $200k over five years). A concrete lever against six-figure medical debt.¹²
Pay near/above general psych, with upside. Nobody publishes a figure for this subspecialty, so budget against general psychiatry — $331,000 on Medscape 2026, $341,977 on Doximity 2025 — and treat the credential as adding demand rather than a pay tier. Cash-pay and telehealth-MAT models add real ceiling on top.¹⁰¹¹
Profound mission alignment. This work is rooted in the same under-resourced communities many FLI students come from, including those hit hardest by addiction. If part of why you want to be a doctor is to serve people the system overlooks, few fields let you do it as directly.

Risks to name honestly:

Pay is comfortable, not maximum. Above general psych, but moderate versus procedural fields. If you're the family breadwinner, the math deserves an honest look. The levers (cash-pay/telehealth clinics, medical directorships) raise the ceiling, but the median is squarely mid-band.
The stigma and emotional load are genuine. You'll keep showing up for patients who relapse, inside a system that undervalues the work. That is a reason to walk in with your eyes open and build support and boundaries early, not a reason to avoid it.

Bottom line: very FLI-favorable. Addiction psychiatry is reachable (undersubscribed, on an IMG/DO-friendly base), cheap in time (one extra year), backed by crisis-scale funded demand and PSLF-rich employers, paying near or above general psych with real upside, and among the most mission-aligned routes in all of medicine for anyone from a community touched by addiction. Hope for the loan-repayment path; plan for the debt either way. And know that if meaning is the thing that gets you out of bed, this is one of the fields where it's easiest to find. If you're not already committed to psychiatry, weigh this against the multidisciplinary Addiction Medicine route, which reaches similar work from a broader set of base residencies.

Subspecialties, focus areas & the two roads in

Addiction psychiatry is itself a subspecialty, reached after a psychiatry residency, so rather than sub-subspecialties, the key branches are the two credentials that lead to this work and the focus areas you can build a career around.

Addiction Psychiatry (ABPN). The psychiatry-native credential (this page): dual-diagnosis-weighted, entered only after a general psychiatry residency.¹⁷
Addiction Medicine (ABPM). The multidisciplinary credential, open from nearly any base specialty; reaches further into general-medical management of addiction. Some physicians hold both. See the companion Addiction Medicine profile.⁷

Focus areas that function like career flavors:

Opioid / MAT-focused practice. Buprenorphine, methadone OTPs, naltrexone; office-based or high-throughput panels.
Dual diagnosis / co-occurring disorders. SUD plus serious mental illness; the field's signature depth.
Adolescent addiction psychiatry. Youth SUD and co-occurring illness.
Pain and addiction. Managing SUD in chronic pain, opioid stewardship.
Forensic / correctional addiction psychiatry. Drug courts, incarcerated populations.
Practice settings as career shape: outpatient MAT/dual-diagnosis clinics · VA · community mental health · inpatient/detox/rehab units · telehealth/cash-pay models · treatment-center medical directorship (an administrative + income lever) · academic addiction psychiatry (teaching, research, protected time).

Fun facts

ABPN has certified Addiction Psychiatry since 1993, three decades old and considerably older than Addiction Medicine, which ABMS recognized only in 2015–16.²⁷
Addiction psychiatry (ABPN, psychiatry-only, dual-diagnosis-weighted) and addiction medicine (ABPM, open from nearly any base) are distinct but overlapping credentials for similar work, and some physicians hold both.⁷
Much of the field's daily impact runs through one drug, buprenorphine, and the 2023 removal of the DEA "X-waiver" means any DEA-registered prescriber can now offer it, widening access dramatically.³
Workforce researchers call addiction work "medicine's best-kept secret," noting most people find it by accident rather than by plan, a big reason the shortage persists despite booming demand.²¹
By one count fewer than ~2,000 addiction psychiatrists serve 46+ million Americans with SUDs, and the demand math is staggering.¹³¹⁴
Roughly 31% of addiction psychiatry match positions went unfilled in 2026 even as overdose deaths and demand stayed near record highs, so the field is undersubscribed by pipeline rather than by need.⁵

Sources

Scope, day-to-day, MAT/MOUD and dual-diagnosis focus, training path (4-yr psychiatry residency + 1-yr ACGME fellowship, PGY-5), and ABPN subspecialty certification requirements (prior general-psychiatry ABPN certification; ≥half-time continuous block; exam every 2 yrs). ABPN, "Addiction Psychiatry" subspecialty certification (accessed 2026) (https://www.abpn.com/become-certified/taking-a-subspecialty-exam/addiction-psychiatry/); American Academy of Addiction Psychiatry (AAAP), Fellowship & scope (2025/26) (https://www.aaap.org/fellowship/ and https://www.aaap.org/); "Addiction psychiatry," Wikipedia (accessed 2026) (https://en.wikipedia.org/wiki/Addiction_psychiatry). ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸ ↩⁹ ↩¹⁰ ↩¹¹ ↩¹² ↩¹³ ↩¹⁴ ↩¹⁵
Subspecialty history — recognized 1993; accredited fellowships grew from ~13 (1997) to ~45–54. "Addiction psychiatry," Wikipedia (accessed 2026) (https://en.wikipedia.org/wiki/Addiction_psychiatry); AAAP Fellowship (https://www.aaap.org/fellowship/). ↩ ↩² ↩³
Income levers and buprenorphine access — cash-pay and telehealth MAT panels, treatment-center medical directorships, and the 2023 MAT Act removal of the DEA X-waiver, which is why any DEA-registered prescriber can now build a buprenorphine panel. ASAM Certification Pathways (https://www.asam.org/education/addiction-medicine-certification/certification-pathways-new). Corrected 2026-08-13: the dollar figures this footnote used to carry (locum hourly rates, remote-role salary ranges) came from Barton Associates and ZipRecruiter and have been removed; the structural claims about the levers stand on their own. On the job board cited here: a posting aggregator is used only as evidence that remote SUD roles exist in volume, which is the one thing it measures well. No pay figure on this page comes from it. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶
Lifestyle — ~42-hr self-reported week, high schedule control, light/no overnight call in outpatient settings, telehealth-MAT compatibility, part-time/combinable (no ADP-specific hours survey; psychiatry + addiction-medicine anchors). SalaryDr Psychiatry Work-Life Balance (2026) (https://www.salarydr.com/specialty-lifestyle/psychiatry); SalaryDr Addiction Medicine, July 2026 (https://www.salarydr.com/specialty/addiction-medicine); Barton Associates Psychiatrist Salary Guide 2026 (https://www.bartonassociates.com/psychiatrist-salary-guide/). ⟳ SalaryDr panel sizes: n=16, n=124. A self-selected physician panel; the n is disclosed here because it is what the figure rests on. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷
NRMP Specialties Matching Service, 2026 appointment year — Addiction Psychiatry: 47 programs, 112 positions offered, 77 filled (68.8%), 22 programs left with an unfilled position, 87 applicants (~0.78 applicant-to-position). Prior cycle for comparison: 104 positions, 61 filled (58.7%), 65 applicants. The same report's Table 6A, Number of Positions Offered and Percent Filled by Graduates of U.S. MD Medical Schools and All Applicants, 2022–2026, gives the four-year series: 112 positions and 68.8% filled (2026), 104 and 58.7% (2025), 124 and 50.8% (2024), 115 and 65.2% (2023). Corrected 2026-08-17: this page read the 2025-to-2026 pair as a trend, headed the bullet "the field is tightening" and told the reader "the direction is away from you." The same table shows the rate swinging by up to eighteen points a cycle and finishing 3.6 points above where it stood in 2023, so a two-year rise is inside the noise. The bullet now prints the series. Many positions are filled outside the match on a rolling or direct basis. NRMP SMS Results and Data, February 2026 (https://www.nrmp.org/wp-content/uploads/2026/02/SMS_Results_and_Data_Report2026.pdf); AAAP Fellowship (https://www.aaap.org/fellowship/). ⟳ ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸
Program counts — ~54 ACGME-accredited Addiction Psychiatry programs (52 continued, 2 initial), 2024–25. ACGME Data Resource Book 2024–2025, Table A.3 (https://www.acgme.org/globalassets/pfassets/publicationsbooks/2024-2025_acgme_databook_document.pdf). ↩ ↩² ↩³
The two distinct credentials — Addiction Psychiatry (ABPN, psychiatry-only) vs. Addiction Medicine (ABPM, multidisciplinary, ABMS-recognized 2015–16, enterable from many base residencies). "Addiction medicine," Wikipedia (accessed 2026) (https://en.wikipedia.org/wiki/Addiction_medicine); ABPM Addiction Medicine overview (https://www.theabpm.org/become-certified/subspecialties/addiction-medicine/); See also the addiction medicine profile on this site, which covers the ABPM route in full. ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷
Matched-cohort composition by school type (2026, 77 matched) — US MD 70.1%, US DO 10.4%, US-IMG 11.7%, non-US IMG 7.8% — used as a directional proxy for %DO/%IMG. NRMP SMS Results and Data, February 2026, Table 2 (https://www.nrmp.org/wp-content/uploads/2026/02/SMS_Results_and_Data_Report2026.pdf). Corrected 2026-08-17: the quick dashboard printed ~20% DO and ~16% US-IMG, roughly double the body on DO, against three places in the file carrying the correct figures. Table 2's row immediately above addiction psychiatry's is Addiction Medicine, at 18.5% DO and 15.0% US IMG, which is the likely origin. The dashboard now reads ~10% DO and ~12% US-IMG. ↩ ↩² ↩³ ↩⁴
Fellow sex, the remaining demographic gaps, and parent-field proxies. Women are 40.5% of addiction psychiatry fellows, 32 of 79 across 54 programs, with 47 men (59.5%) and none unreported: ACGME Data Resource Book, Academic Year 2024-2025, Table C.21 (https://www.acgme.org/globalassets/pfassets/publicationsbooks/2024-2025_acgme_databook_document.pdf). No race or ethnicity breakdown and no practicing-workforce demographic table exist for the subspecialty. Parent-field proxies: general psychiatry ~42–44% women (2022), all-physician ~38.7% women (2024); ~29% of practicing psychiatrists are IMGs (2020). Corrected 2026-08-17: this page said subspecialty demographics were not cleanly published and that Table C.21 gives head counts rather than percentages with a meaningful unknown share. C.21 prints both counts and percentages, and addiction psychiatry's unreported share is zero, so the 40.5% is now stated rather than declined. The gap language is kept for race and ethnicity and for the practicing workforce, where it is real. AAMC Report on Residents Table B3 (https://www.aamc.org/data-reports/students-residents/data/report-residents/2024/table-b3-number-active-residents-type-medical-school-gme-specialty-and-gender); Premed Catalyst citing AAMC 2022 (https://www.premedcatalyst.com/post/women-in-medicine-statistics); Academic Psychiatry, "International Medical Graduates in the US Psychiatry Workforce" (2020 data / 2022) (https://link.springer.com/article/10.1007/s40596-022-01635-y). ⟳ ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶
The absence of an addiction-psychiatry compensation figure, and what was removed. Corrected 2026-08-13. This page previously carried a ~$345,000–$355,000 estimated median, a full percentile ladder (10th $265k through 90th ~$500k), a subspecialty table putting addiction at ~$355k against forensic at ~$395k, remote buprenorphine roles at $109k–$250k, and locum rates of ~$225–$235/hr. Those traced to SalaryDr, ZipRecruiter, Barton Associates and a staffing vendor's blog. All four are excluded sources on this site, and the figures were removed rather than relabeled as estimates: a scraped job-posting average is evidence about job postings, not about earnings. Neither Medscape nor Doximity publishes any psychiatry subspecialty, so no defensible addiction-psychiatry figure exists at any tier, and the page now anchors to general psychiatry as an explicit inference. A search of Student Doctor Network for practitioners reporting their own addiction-psychiatry compensation found speculation about what a high-volume cash-pay panel could theoretically bill and no datable self-reports, so no community estimate is offered either. ⟳ SalaryDr does not publish a panel size for the page cited here (its blog and career-guide pages omit the n that its per-specialty pages carry), so the panel-size caveat this site attaches to a self-selected panel cannot be quantified for this figure. Treat it as a self-selected panel of unknown size. ↩ ↩²
The two published general-psychiatry figures, both surveys with stated methodology, neither of which breaks out a subspecialty. Medscape Physician Compensation Report 2026 (2025 earnings) — psychiatry $331,000, 24th of the 29 specialties it covers (https://www.medscape.com/p11/medscape-psychiatrist-compensation-report-2026-evaluating-2026a1000e9a; the primary report is paywalled and returns HTTP 402). Doximity 2025 Physician Compensation Report (2024 earnings, ~37,000 US physicians) — psychiatry $341,977, openable directly (https://www.doximity.com/reports/physician-compensation-report/2025). Both publish means rather than medians and neither is inflation-adjusted. Corrected 2026-08-13: this page previously described Medscape as moving from ~$323k to ~$331k and called that a dip. It is a rise, and the earlier-edition figure has no verified source on this site, so the year-over-year direction has been dropped rather than reversed. ⟳ ↩ ↩² ↩³
PSLF-rich and loan-repayment employers. NHSC Loan Repayment Program, https://nhsc.hrsa.gov/loan-repayment/nhsc-loan-repayment-program: up to $75,000 for a full-time two-year commitment for primary-care disciplines in a primary-care HPSA, and up to $50,000 for behavioral and mental-health disciplines, which is the row an addiction psychiatrist sits in — the program states that a provider in an eligible discipline delivering mental or behavioral health services does not qualify for the increased primary-care amount. NHSC Rural Community Loan Repayment Program, https://nhsc.hrsa.gov/loan-repayment/nhsc-rural-community-loan-repayment-program: up to $100,000, for three years of full-time substance-use-disorder treatment at a rural NHSC-approved SUD facility. That second program is written for this field's work, which is why both caps are given here rather than one. nhsc.hrsa.gov returns HTTP 403 to every non-browser client, so the award schedule is read off the Indian Health Service's mirror of the same terms, https://www.ihs.gov/loanrepayment/nhsc-loan-repayment-program/ , on 2026-08-17. VA Education Debt Reduction Program: up to $200,000 over five years, capped at $40,000 a year, and structured as reimbursement of payments made rather than as forgiveness. Employment concentration: HRSA, State of the Behavioral Health Workforce 2025 (https://bhw.hrsa.gov/sites/default/files/bureau-health-workforce/data-research/Behavioral-Health-Workforce-Brief-2025.pdf); MASC Medical, Psychiatrist Salaries & Trends 2025 (https://mascmedical.com/psychiatrist-salaries-compensation-trends-in-2025-a-recruiters-guide/). Swept 2026-08-17: this page said "NHSC up to $100,000 for a 2-year HPSA commitment" in the compensation section and again in the FLI section, and the figure reached it through the recruiter blog rather than through the program. The $100,000 belongs to the Rural Community LRP and costs three years of rural SUD service; the two-year HPSA commitment the sentence described pays an addiction psychiatrist $50,000. Both programs are now named with their own terms. The same error was corrected on the psychiatry, child and adolescent psychiatry and geriatric psychiatry profiles. ⟳ ↩ ↩² ↩³
Meaning, the overdose-crisis frontline, and the critical workforce need: American Academy of Addiction Psychiatry (AAAP), Fellowship page (2025/26) (https://www.aaap.org/fellowship/), which is also where the "biggest public health challenge facing the United States" phrasing comes from. The denominator is SAMHSA's own: 48.5 million people aged 12 or older, 17.1% of that population, met criteria for a past-year substance use disorder in 2023 — Key Substance Use and Mental Health Indicators in the United States: Results from the 2023 National Survey on Drug Use and Health (https://www.samhsa.gov/data/sites/default/files/reports/rpt47095/National%20Report/National%20Report/2023-nsduh-annual-national.htm). Swept 2026-08-17: this page carried two values for one fact and neither came from the survey — "~50 million" here, attributed to AAAP and dated 2022, and "46M+" at [^17], attributed to a fellowship directors' guide. Both are readings of NSDUH at different vintages, and the site's addiction medicine profile had already been moved to the survey's own current figure, so the corpus held three numbers for one denominator. It now states NSDUH's 2023 figure once, with the percentage beside it so the population is named rather than implied. ⟳ ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷
Workforce size and demand tailwinds — ~2,000 ABPN-certified addiction psychiatrists (<~7,000 addiction physicians of any route) against the 48.5 million Americans aged 12 or older with a past-year SUD in 2023, which is SAMHSA's figure and is given with its denominator at [^14]; SAMHSA/HRSA/opioid-settlement funding. Swept 2026-08-17: the ACAAM guide's "46M+" stood here as a second value for the same fact. Psychiatric Services (2020–21) (https://psychiatryonline.org/doi/10.1176/appi.ps.202000565); ACAAM Fellowship Program Directors' Guide, Oct 2025 (https://www.acaam.org/assets/docs/Fellowship/ADM%20FD%20Guide_Final_10.15.2025.pdf). ⟳ ↩ ↩² ↩³ ↩⁴
No publisher reports satisfaction or "would choose again" for addiction psychiatry, and the by-specialty would-choose-again tables circulating on salary-aggregator sites carry no underlying survey. The parent-field signal is Medscape's happiness-and-balance question, on which psychiatry ranks near the top; the specialty-level figure itself is behind Medscape's paywall and is reported here only as a rank, not a number. ↩ ↩² ↩³ ↩⁴
Burnout — general psychiatry ~39% (Medscape 2024, 2023 data, 9,226 physicians), tied ~2nd-lowest vs. EM 63% (parent-field anchor; no ADP-isolated figure). Medscape Physician Burnout & Depression Report 2024, via Healthgrades (https://resources.healthgrades.com/pro/the-most-and-least-burned-out-physicians-by-specialty). ⟳ A second, freely readable instrument: the AMA's 2025 Organizational Biopsy (~19,000 physicians, 38 states) puts Psychiatry at 31.6% against a 41.9% all-physician average, https://www.ama-assn.org/practice-management/physician-health/these-9-physician-specialties-report-highest-burnout-rates. It is primary where Medscape reaches this page through relays, and its baseline sits seven points below Medscape's 49% — the two never belong in the same sentence, and a cross-specialty rank must name which survey it comes from. Corrected 2026-08-17: this site prefers AMA wherever it publishes a row, because it is free, primary and current, and uses Medscape only where AMA has none. AMA has a Psychiatry row. Both reader-facing surfaces, the Quick dashboard and the Wellbeing lede, led with the relayed Medscape figure anyway while this footnote declared AMA primary. Both now lead with AMA and keep Medscape as the second instrument, in its own sentence. The rank moves with it: "tied roughly 2nd-lowest" is Medscape's ordering of its twenty rows and belongs to Medscape alone, and the AMA list puts psychiatry sixth of the six it names at the bottom (infectious diseases 23.3%, ophthalmology 25.8%, pathology 28.3%, nephrology 29.3%, dermatology 31.5%, psychiatry 31.6%). ↩
Burnout among hospital-based addiction providers driven by systemic under-resourcing and stigma; meaning, purpose, and team support build resilience. Serowik et al., Journal of Substance Abuse Treatment, 2022 (https://www.sciencedirect.com/science/article/abs/pii/S0740547222002069). ↩ ↩² ↩³ ↩⁴ ↩⁵
Stigma and "medical gaslighting" around addiction as lethal; fewer than 1 in 5 of ~48M Americans with SUD get treatment. Taylor Moss, MPH & Devika Bhushan, MD — KevinMD, 2026 (https://kevinmd.com/2026/07/how-addiction-stigma-in-health-care-costs-lives.html). ↩ ↩²
Culture / who-gravitates and synthesized online sentiment (mission-driven, non-judgmental, harm-reduction-minded, resilient, advocacy-driven, dual-diagnosis-fascinated, less status-obsessed; comfortable with chronic relapsing disease and slow wins). Synthesized from physician forums (r/psychiatry, r/medicine, r/FamilyMedicine, SDN — paraphrased, not quoted) and other profiles on this site. ↩ ↩² ↩³
Harm reduction as fundamental as "do no harm"; the emotional core of the work. Megana Dwarakanath, MD — Doximity Op-Med, "Harm Reduction Is as Useful as 'Do No Harm'" (https://opmed.doximity.com/articles/harm-reduction-is-as-useful-as-do-not-harm). ↩
Addiction care "one of medicine's best-kept secrets" — found by accident, sustaining the shortage. EurekAlert!/BMC Medical Education, 2026 (https://www.eurekalert.org/news-releases/1130630). ↩ ↩²

Researched with AI assistance and reviewed by hand. How this site is made